Stockreport

Contineum Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]

Contineum Therapeutics, Inc. - Common stock  (CTNM) 
PDF SAN DIEGO, March 13, 2026 BUSINESS WIRE )--Contineum Therapeutics, Inc. (NASDAQ: CTNM) (Contineum or the Company), a clinical-stage biopharmaceutical company pioneering [Read more]